| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
REGULAR ARTICLES |
Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
Correspondence to Dr. Midori Awazu, Department of Pediatrics, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. Phone: 81 3 3353 1211; Fax: 81 3 5379 1978; E-mail: awazu{at}mc.med.keio.ac.jp
Abstract. Various growth factors and vasoactive substances are implicated in the pathogenesis of renal growth seen in early diabetes mellitus (DM). Mitogen-activated protein kinase (MAPK) is an important mediator of these extracellular stimuli. Protein kinase C (PKC), an enzyme known to be stimulated in DM, also activates MAPK. Thus, MAPK activity was examined in glomeruli from streptozotocin-induced DM rats. MAPK activity, measured as myelin basic protein kinase, was elevated by approximately 50% in DM versus controls (CON). Increased protein contents of p42mapk and p44mapk, as well as increased tyrosine phosphorylation and mobility shift of p42mapk, were also observed in DM. Tyrosine dephosphorylation of pp42mapk, on the other hand, assessed by incubating glomerular membrane with or without sodium orthovanadate (vanadate), was significantly diminished in DM. Protein expression of MAPK phosphatase-1 (MKP-1), a dual specificity phosphatase that inactivates MAPK, was approximately 60% of CON. Reduction in MKP-1 was reproduced in cultured mesangial cells grown under high glucose (30 mM; HG). The suppression of MKP-1 was PKC-dependent since incubation of HG cells with phorbol 12-myristate 13-acetate for 24 h abolished it. Furthermore, calcium ionophore A23187 reversed the suppression, suggesting that blunted Ca2+ signalling, characteristic of HG cells secondary to PKC stimulation, may be the cause. These results demonstrate that glomerular MAPK is activated in DM by multiple mechanisms i.e., increases in protein contents, increased phosphorylation, and decreased dephosphorylation of the enzyme due to suppression of MKP-1. These alterations may have an implication in the pathogenesis of diabetic nephropathy.
This article has been cited by other articles:
![]() |
F. Dorado, S. Velasco, A. Esparis-Ogando, M. Pericacho, A. Pandiella, J. Silva, J. M. Lopez-Novoa, and A. Rodriguez-Barbero The mitogen-activated protein kinase Erk5 mediates human mesangial cell activation Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3403 - 3411. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-C. Lu, Z. Wang, X. Feng, P. Chuang, W. Fang, Y. Chen, S. Neves, A. Maayan, H. Xiong, Y. Liu, et al. Retinoic Acid Utilizes CREB and USF1 in a Transcriptional Feed-Forward Loop in Order To Stimulate MKP1 Expression in Human Immunodeficiency Virus-Infected Podocytes Mol. Cell. Biol., September 15, 2008; 28(18): 5785 - 5794. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ichihara, F. Suzuki, T. Nakagawa, Y. Kaneshiro, T. Takemitsu, M. Sakoda, A.H.M. N. Nabi, A. Nishiyama, T. Sugaya, M. Hayashi, et al. Prorenin Receptor Blockade Inhibits Development of Glomerulosclerosis in Diabetic Angiotensin II Type 1a Receptor-Deficient Mice J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1950 - 1961. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ragolia, T. Palaia, C. E. Hall, J. K. Maesaka, N. Eguchi, and Y. Urade Accelerated Glucose Intolerance, Nephropathy, and Atherosclerosis in Prostaglandin D2 Synthase Knock-out Mice J. Biol. Chem., August 19, 2005; 280(33): 29946 - 29955. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lang Regulating Renal Drug Elimination? J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1535 - 1536. [Full Text] [PDF] |
||||
![]() |
B. F. Schrijvers, A. S. De Vriese, and A. Flyvbjerg From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines Endocr. Rev., December 1, 2004; 25(6): 971 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hayashida and H. W. Schnaper High Ambient Glucose Enhances Sensitivity to TGF-{beta}1 via Extracellular Signal--Regulated Kinase and Protein Kinase C{delta} Activities in Human Mesangial Cells J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2032 - 2041. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Pueyo, M. Challah, D. Gauguier, L. Louedec, M. Philippe, R. Gaertner, M. Marre, J.-B. Michel, and M.-P. Jacob Transforming Growth Factor-{beta}1 Production Is Correlated With Genetically Determined ACE Expression in Congenic Rats: A Possible Link Between ACE Genotype and Diabetic Nephropathy Diabetes, April 1, 2004; 53(4): 1111 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nishiyama, M. Yoshizumi, H. Hitomi, S. Kagami, S. Kondo, A. Miyatake, M. Fukunaga, T. Tamaki, H. Kiyomoto, M. Kohno, et al. The SOD Mimetic Tempol Ameliorates Glomerular Injury and Reduces Mitogen-Activated Protein Kinase Activity in Dahl Salt-Sensitive Rats J. Am. Soc. Nephrol., February 1, 2004; 15(2): 306 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fujita, S. Omori, K. Ishikura, M. Hida, and M. Awazu ERK and p38 mediate high-glucose-induced hypertrophy and TGF-{beta} expression in renal tubular cells Am J Physiol Renal Physiol, January 1, 2004; 286(1): F120 - F126. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Haneda, D. Koya, M. Isono, and R. Kikkawa Overview of Glucose Signaling in Mesangial Cells in Diabetic Nephropathy J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1374 - 1382. [Full Text] [PDF] |
||||
![]() |
H. Kawano, S. Kim, K. Ohta, T. Nakao, H. Miyazaki, T. Nakatani, and H. Iwao Differential Contribution of Three Mitogen-Activated Protein Kinases to PDGF-BB-Induced Mesangial Cell Proliferation and Gene Expression J. Am. Soc. Nephrol., March 1, 2003; 14(3): 584 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Awazu, S. Omori, K. Ishikura, M. Hida, and H. Fujita The Lack of Cyclin Kinase Inhibitor p27Kip1 Ameliorates Progression of Diabetic Nephropathy J. Am. Soc. Nephrol., March 1, 2003; 14(3): 699 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cellier, M. Mage, J. Duchene, C. Pecher, R. Couture, J.-L. Bascands, and J.-P. Girolami Bradykinin reduces growth factor-induced glomerular ERK1/2 phosphorylation Am J Physiol Renal Physiol, February 1, 2003; 284(2): F282 - F292. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. R. Danesh, M. M. Sadeghi, N. Amro, C. Philips, L. Zeng, S. Lin, A. Sahai, and Y. S. Kanwar 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy PNAS, June 11, 2002; 99(12): 8301 - 8305. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. I. Whiteside and J. A. Dlugosz Mesangial cell protein kinase C isozyme activation in the diabetic milieu Am J Physiol Renal Physiol, June 1, 2002; 282(6): F975 - F980. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Silveira, C. E. Bacchi, G. A. Pinto, and J. B. L. de Faria The Genetics of Hypertension Modifies the Renal Cell Replication Response Induced by Experimental Diabetes Diabetes, May 1, 2002; 51(5): 1529 - 1534. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tsiani, P. Lekas, I. G. Fantus, J. Dlugosz, and C. Whiteside High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E161 - E169. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Joussen, S. Huang, V. Poulaki, K. Camphausen, W.-D. Beecken, B. Kirchhof, and A. P. Adamis In Vivo Retinal Gene Expression in Early Diabetes Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 3047 - 3057. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. PURVES, A. MIDDLEMAS, S. AGTHONG, E. B. JUDE, A. J. M. BOULTON, P. FERNYHOUGH, and D. R. TOMLINSON A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy FASEB J, November 1, 2001; 15(13): 2508 - 2514. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ceolotto, A. Gallo, M. Sartori, R. Valente, E. Baritono, A. Semplicini, and A. Avogaro Hyperglycemia Acutely Increases Monocyte Extracellular Signal-Regulated Kinase Activity in Vivo in Humans J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1301 - 1305. [Abstract] [Full Text] |
||||
![]() |
G. Wolf, R. Schroeder, G. Zahner, R. A. K. Stahl, and S. J. Shankland High Glucose-Induced Hypertrophy of Mesangial Cells Requires p27Kip1, an Inhibitor of Cyclin-Dependent Kinases Am. J. Pathol., March 1, 2001; 158(3): 1091 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. ISONO, M. C. I.-D. L. CRUZ, S. CHEN, S. W. HONG, and F. N. ZIYADEH Extracellular Signal-Regulated Kinase Mediates Stimulation of TGF-{beta}1 and Matrix by High Glucose in Mesangial Cells J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2222 - 2230. [Abstract] [Full Text] |
||||
![]() |
W. Tian, Z. Zhang, and D. M. Cohen MAPK signaling and the kidney Am J Physiol Renal Physiol, October 1, 2000; 279(4): F593 - F604. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Dlugosz, S. Munk, J. Kapor-Drezgic, H. J. Goldberg, I. G. Fantus, J. W. Scholey, and C. I. Whiteside Stretch-induced mesangial cell ERK1/ERK2 activation is enhanced in high glucose by decreased dephosphorylation Am J Physiol Renal Physiol, October 1, 2000; 279(4): F688 - F697. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673